Sanitizing Wipes For Skin Supplier – Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) – Lircon
Short Description:
Sanitizing Wipes For Skin Supplier – Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) – Lircon Detail:
Major ingredient and concentration
Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) is a disinfectant with Ethacridine Lactate and Dodecyl Dimethyl Benzyl Ammonium Chloride as the main active ingredients. The Ethacridine Lactate content is 0.22g/L-0.022g/L(W/V), and the Dodecyl Dimethyl Benzyl Ammonium Chloride content is 0.42g/L-0.042g/L(W/V).
Germicidal spectrum
Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) can kill the microorganisms such as enteric pathogenic bacteria, pyogenic coccus, pathogenic yeast and hospital infection common germs.
Features and Benefits
1. For rinsing, cleaning and sterilizing the entire skin surface.
List of Uses
Animal care facilities | Military bases |
Community health centers | Operating rooms |
Donning rooms | Orthodonist offices |
Emergency medical settings | Outpatient surgical centers |
Hospitals | Schools |
Laboratories | Surgical centers |
Product detail pictures:
Related Product Guide:
Our solutions are broadly acknowledged and dependable by users and may meet consistently developing economic and social requires for Sanitizing Wipes For Skin Supplier – Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) – Lircon, The product will supply to all over the world, such as: Juventus, Croatia, Lahore, The working experience in the field has helped us forged a strong relations with customers and partners both in domestic and international market. For years, our products and solutions have been exported to more than 15 countries in the world and have been widely used by customers.
By Anna from Puerto Rico - 2017.09.16 13:44
The supplier cooperation attitude is very good, encountered various problems, always willing to cooperate with us, to us as the real God.
By Martha from Canada - 2018.11.11 19:52